Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma

This study is currently recruiting participants.

Study NCT00073957 Information provided by National Cancer Institute (NCI)

First Received: December 10, 2003 Last Updated: July 7, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	June 2010 (Final data collection date for primary outcome measure)